Adjuvant treatment of colorectal cancer at the turn of the century: European and US perspectives. (Q34181264)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11249040%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

Adjuvant treatment of colorectal cancer at the turn of the century: European and US perspectives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11249040%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11249040%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

J Wils

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11249040%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P O'Dwyer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11249040%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11249040%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11249040%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11249040%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11249040%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

13-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11249040%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Prolongation of the disease-free interval in surgically treated rectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Adjuvant therapy in large bowel adenocarcinoma: long-term results of a Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Adjuvant treatment of colon cancer: where to go from here?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Mechanism of synergy of levamisole and fluorouracil: induction of human leukocyte antigen class I in a colorectal cancer cell line

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Enigma of fluorouracil and levamisole

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

The tea leaves of small trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Micrometastases and survival in stage II colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Adjuvant cytotoxic liver perfusion for colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control. Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Adjuvant treatment of colon cancer. A plea for a large-scale European trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

The establishment of a large collaborative trial programme in the adjuvant treatment of colon cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Effective surgical adjuvant therapy for high-risk rectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Survival after postoperative combination treatment of rectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Improved survival with preoperative radiotherapy in resectable rectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Adjuvant therapy for rectal cancer--a good first step

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Combined modality adjuvant treatment of high-risk rectal cancer: a treatment of choice or a choice of treatment?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Adjuvant chemotherapy in colorectal carcinoma: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008357725209

7 January 2021

Identifiers

DOI

10.1023/A:1008357725209

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11249040%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference